Venova Technologies Inc.
Cambridge, MA Venova Technologies
- UEI
- Z9ZUREFJVHF9
- CAGE
- 8JQ25
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 750 Main St, Cambridge, MA 02139, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A novel, non-hormonal, long-acting female contraceptive device - project summary venova technologies is a women-led… | National Institute of Child Health and Human Development | $383,114 | |
| Development of a novel, non-hormonal female contraceptive device to submit IDE - project summary venova technologies… | National Institute of Child Health and Human Development | $2,226,234 | |
| Development of a novel, non-hormonal female contraceptive device - project summary the applicant, venova technologies,… | National Institute of Child Health and Human Development | $600,134 |
About Venova Technologies Inc.
Venova Technologies Inc. is a women-led and minority-owned medical device startup based in Cambridge, Massachusetts, registered in the System for Award Management (SAM) with a registration valid through March 2026. The company specializes in innovative medical device development, with a particular focus on women's reproductive health technologies. Its business structure is a for-profit corporate entity that has been recognized with multiple business certifications, including Woman Owned Small Business, Asian-Pacific American Owned, and DOT Certified DBE.
Venova Technologies Inc. has secured multiple federal grants from the National Institute of Child Health and Human Development (NICHD) through Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, all centered on developing a novel, non-hormonal female contraceptive device. The company's primary research objective is to create a long-acting, reversible contraceptive solution that addresses critical unmet needs in birth control by avoiding hormonal and copper-related side effects. Their grant-funded projects have focused on iterative device design, technical milestone advancement, and preparing for future biocompatibility testing and clinical trials. The grants, ranging from Phase I to Phase II, total approximately $383,114 and are structured to support the company's innovative approach to contraceptive technology, with project completion dates extending to August 2025. The research aims to develop a contraceptive method that does not interfere with natural menstrual cycles and provides an alternative to existing hormonal and copper-based contraceptive options.
Quick answers
What is Venova Technologies Inc.'s UEI?
Venova Technologies Inc.'s Unique Entity ID (UEI) in SAM.gov is Z9ZUREFJVHF9.
What is Venova Technologies Inc.'s CAGE code?
Venova Technologies Inc.'s CAGE code is 8JQ25.
Where is Venova Technologies Inc. located?
Venova Technologies Inc.'s physical address in SAM.gov is 750 Main St, Cambridge, MA 02139, USA.
Is Venova Technologies Inc. registered in SAM.gov?
Yes. Venova Technologies Inc.'s SAM.gov registration is active through January 7, 2027.
What is Venova Technologies Inc.'s most recent federal award?
Venova Technologies Inc.'s most recent federal grant award is A novel, non-hormonal, long-acting female contraceptive device - project summary venova technologies is a women-led… (R43HD116640), from National Institute of Child Health and Human Development, on September 13, 2024.
On GovTribe
See Venova Technologies Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors